Rare Chemicals

CPX-351 View larger

CPX-351

AT31088

CAS 1256639-86-7

More details

Molarity Calculation Cart®

HOW TO ORDER

$1,080.00

$1,080.00 per mg

Quantity Discount Table - Order More To Get More Price Discount

QuantitymgUnit Price ($/mg or $/Unit)Final Price
1100 $486.00 Total: $48,600.00
150 $561.60 Total: $28,080.00
125 $658.80 Total: $16,470.00
110 $777.60 Total: $7,776.00
15 $918.00 Total: $4,590.00

Data sheet

Molecular FormulaC36H42N4O15
Molecular Weight770.74
CAS Numbers1256639-86-7
Storage Condition0C Short Term, -20C Long Term
SolubilityDMSO
Purity98% by HPLC
SMILES CodeO[C@@H]1[C@@H](O[C@H](CO)[C@H]1O)N2C(=O)N=C(N)C=C2.OC=1C2=C([C@@H](O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C[C@@](C(C)=O)(O)C2)C(O)=C4C1C(=O)C=5C(C4=O)=C(OC)C=CC5
ReferencesLin TL, Newell LF, Stuart RK, Michaelis LC, Rubenstein E, Pentikis HS, Callahan T, Alvarez D, Liboiron BD, Mayer LD, Wang Q, Banerjee K, Louie AC. A phase 2 study to assess the pharmacokinetics and pharmacodynamics of CPX-351 and its effects on cardiac repolarization in patients with acute leukemias. Cancer Chemother Pharmacol. 2019 May 16. doi 10.1007s00280-019-03856-9. [Epub ahead of print] PubMed PMID 31098682.

More info

CPX-351 (Vyxeos) is a liposomal encapsulant of cytarabine and Zoerythromycin with potential antitumor activity and can be used in the study of acute myeloid leukemia.